Alector Inc 's Revenue in the fiscal year 2025 $ 21.05 millions
Alector Inc 's Revenue in the fiscal year 2024 $ 100.56 millions
Alector Inc 's Revenue in the fiscal year 2023 $ 97.06 millions
Alector Inc 's Revenue in the fiscal year 2022 $ 133.62 millions
Alector Inc 's Revenue in the fiscal year 2021 $ 207.09 millions
ALEC Revenue third quarter 2026 Y/Y Growth Comment
Alector Inc achieved in the third quarter 2026, above Company average Revenue surge of 4895.89% year on year, to $ 162.87 millions.
Looking into third quarter 2026 results within Biotechnology & Pharmaceuticals industry 58 other companies have achieved higher Revenue growth. While Alector Inc ' s Revenue doubling of 4895.89% ranks overall at the positon no. 3808 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Alector Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
2677.3 %
111.56 %
-93.23 %
(Sep 30 2021)
ALEC's III. Quarter Q/Q Revenue Comment
Alector Inc achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 4805.6%, to $ 162.87 millions, from $3.32 millions in the second quarter. ALEC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Biotechnology & Pharmaceuticals industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Alector Inc 's Revenue growth quarter on quarter, overall rank is 81.
Alector Inc achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 4805.6%, to $ 162.87 millions, from $3.32 millions in the second quarter. ALEC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Biotechnology & Pharmaceuticals industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Alector Inc 's Revenue growth quarter on quarter, overall rank is 81.
Alector Inc 's 12 Months Revenue Growth Year on Year
Alector Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 151.23% year on year, to $ 173 millions if the fiscal year would have ended in Sep 30 2026. Alector Inc 's trailing twelve months Revenue growth was higher than company's average 130.23% and higher than -82.91% growth in Jun 30 2026.
In the Healthcare sector 94 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 369, from total ranking in previous quarter at 2153.
Alector Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 151.23% year on year, to $ 173 millions if the fiscal year would have ended in Sep 30 2026. Alector Inc 's trailing twelve months Revenue growth was higher than company's average 130.23% and higher than -82.91% growth in Jun 30 2026. The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 1151.31 % increase from $13.86 millions in the period from Jun 30 2026 to Sep 30 2025.
In the Healthcare sector 94 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 369, from total ranking in previous quarter at 2153.
About Alector Inc Revenue Growth Rates (ALEC), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
5,723.64%